Jenny Karlsson

Laboratory Researcher
More filtering options
  1. 2019
  2. The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis

    Linda Holmquist Mengelbier, Lindell-Munther, S., Hiroaki Yasui, Jansson, C., Esfandyari, J., Jenny Karlsson, Lau, K., Hui, C. C., Daniel Bexell, Hopyan, S. & David Gisselsson, 2019 Jan, In : Journal of Pathology. 247, 1

    Research output: Contribution to journalArticle

  3. Clonal evolution through genetic bottlenecks and telomere attrition: Potential threats to in vitro data reproducibility

    David Gisselsson, Lichtenzstejn, D., Kachko, P., Jenny Karlsson, Manor, E. & Mai, S., 2019, In : Genes Chromosomes and Cancer. 58, 7, p. 452-461

    Research output: Contribution to journalReview article

  4. 2018
  5. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers

    Anders Valind, Wessman, S., Pal, N., Jenny Karlsson, Tord Jonson, Sandstedt, B. & David Gisselsson, 2018 Nov 1, In : Pediatric Blood and Cancer. 65, 11, e27301.

    Research output: Contribution to journalArticle

  6. Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer

    Jenny Karlsson, Anders Valind, Linda Holmquist Mengelbier, Bredin, S., Louise Cornmark, Jansson, C., Wali, A., Johan Staaf, Viklund, B., Ingrid Øra, Anna Börjesson, Backman, T., Noémie Braekeveldt, Sandstedt, B., Pal, N., Isaksson, A., Lackner, B. G., Tord Jonson, Daniel Bexell & David Gisselsson, 2018 Jul, In : Nature Genetics. 50, 7, p. 944-950

    Research output: Contribution to journalArticle

  7. Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma

    Braekeveldt, N., Von Stedingk, K., Fransson, S., Martinez-Monleon, A., Lindgren, D., Axelson, H., Levander, F., Willforss, J., Hansson, K., Øra, I., Backman, T., Börjesson, A., Beckman, S., Esfandyari, J., Berbegall, A. P., Noguera, R., Karlsson, J., Koster, J., Martinsson, T., Gisselsson, D. & 2 othersSven Påhlman & Daniel Bexell, 2018, In : Cancer Research. 78, 20, p. 5958-5969 12 p.

    Research output: Contribution to journalArticle

  8. 2016
  9. 2015
  10. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.

    Holmquist Mengelbier, L., Karlsson, J., Lindgren, D., Valind, A., Lilljebjörn, H., Jansson, C., Bexell, D., Braekeveldt, N., Ameur, A., Jonson, T., Kultima, H. G., Isaksson, A., Asmundsson, J., Versteeg, R., Rissler, M., Fioretos, T., Sandstedt, B., Börjesson, A., Backman, T., Pal, N. & 3 othersIngrid Øra, Mayrhofer, M. & David Gisselsson Nord, 2015, In : Nature Communications. 6, 6125.

    Research output: Contribution to journalArticle

  11. 2014
  12. 2013
  13. 2012
  14. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney

    O'Meara, E., Stack, D., Lee, C-H., Garvin, A. J., Morris, T., Argani, P., Han, J. S., Jenny Karlsson, David Gisselsson Nord, Leuschner, I., Gessler, M., Graf, N., Fletcher, J. A. & O'Sullivan, M. J., 2012, In : Journal of Pathology. 227, 1, p. 72-80

    Research output: Contribution to journalArticle

  15. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.

    Sehic, D., Jenny Karlsson, Sandstedt, B. & David Gisselsson Nord, 2012, In : Pediatric Blood & Cancer. 59, 1, p. 62-68

    Research output: Contribution to journalArticle

  16. 2011
  17. 2010
  18. 2009
  19. Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.

    Pettersson, H., Alexander Pietras, Thorén, M., Jenny Karlsson, Johansson, L., Shoshan, M. C. & Sven Påhlman, 2009, In : Molecular Cancer Therapeutics. 8, 1, p. 160-170

    Research output: Contribution to journalArticle

  20. 2007
  21. Arsenic trioxide and neuroblastoma cytotoxicity.

    Pettersson, H., Jenny Karlsson, Alexander Pietras, Ingrid Øra & Sven Påhlman, 2007, In : Journal of Bioenergetics and Biomembranes. 39, 1, p. 35-41

    Research output: Contribution to journalReview article

  22. Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.

    Jenny Karlsson, Alexander Pietras, Beckman, S., Pettersson, H., Christer Larsson & Sven Påhlman, 2007, In : Oncogene. 26, 42, p. 6150-6159

    Research output: Contribution to journalArticle

  23. 2005
  24. Effects of arsenic trioxide and hypoxia in multidrug-resistant neuroblastoma

    Jenny Karlsson, 2005, Lund University, Faculty of Medicine. 115 p.

    Research output: ThesisDoctoral Thesis (compilation)

  25. Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.

    Jenny Karlsson, Edsjö, A., Sven Påhlman & Pettersson, H., 2005, In : Molecular Cancer Therapeutics. 4, 7, p. 1128-1135

    Research output: Contribution to journalArticle

  26. 2004
  27. Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation.

    Edsjö, A., Helén Nilsson, Vandesompele, J., Jenny Karlsson, Pattyn, F., Culp, L. A., Speleman, F. & Sven Påhlman, 2004, In : Laboratory Investigation. 84, 4, p. 406-417

    Research output: Contribution to journalArticle

  28. 2003
  29. The Lim-only protein LMO4 modulates the transcriptional activity of HEN1.

    Manetopoulos, C., Hansson, A., Jenny Karlsson, Jönsson, J-I. & Håkan Axelson, 2003, In : Biochemical and Biophysical Research Communications. 307, 4, p. 891-899

    Research output: Contribution to journalArticle